Javelin Pharmaceuticals (JAV) Receives Notice From NYSE Amex LLC of Non-Compliance
6/7/2010 6:11:24 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") announces that on May 28, 2010, Javelin received notice from the staff of the NYSE Amex LLC (the “Exchange”) that Javelin is not in compliance with Section 1003(a)(iv) of Part 10 of the NYSE Amex LLC Company Guide. Specifically, after reviewing Javelin’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, the Exchange staff indicated that Javelin has sustained losses which are so substantial in relation to its overall operation or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the Exchange, as to whether Javelin will be able to continue operations and/or meet its obligations as they mature.
comments powered by